Identification of mammalian proteins that collaborate with type III secretion system function: involvement of a chemokine receptor in supporting translocon activity

mBio

Volumn 6, Issue 1, 2015, Pages

  Sheahan, Kerri Lynn ^a   Isberg, Ralph R ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUXILIN; BACTERIAL PROTEIN; CHEMOKINE RECEPTOR; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR8; CLATHRIN; CLATHRIN HEAVY CHAIN; COAT PROTEIN COMPLEX I; COAT PROTEIN COMPLEX II; GENOMIC DNA; HEAT SHOCK COGNATE PROTEIN 70; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; SHORT HAIRPIN RNA; TRANSLOCON; UNCLASSIFIED DRUG; YERSINIA OUTER PROTEIN B; YERSINIA OUTER PROTEIN D; YERSINIA OUTER PROTEIN E; OUTER MEMBRANE PROTEIN; SMALL INTERFERING RNA; TYPE III SECRETION SYSTEM; VIRULENCE FACTOR; YOPE PROTEIN, YERSINIA;

ANIMAL CELL; ARTICLE; BACTERIAL TRANSLOCATION; CELL MEMBRANE TRANSPORT; CELL POPULATION; CELL SURFACE; CHANNEL GATING; CONTROLLED STUDY; CYTOSKELETON; CYTOTOXICITY; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENETIC TRANSFECTION; HOST CELL; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN ASSEMBLY; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; RNA INTERFERENCE; RNA SEQUENCE; TRANS GOLGI NETWORK; TYPE III SECRETION SYSTEM; YERSINIA PSEUDOTUBERCULOSIS; ANIMAL; CELL LINE; GENE SILENCING; GENETICS; HIGH THROUGHPUT SEQUENCING; HOST PATHOGEN INTERACTION; KNOCKOUT MOUSE; METABOLISM; PROTEIN TRANSPORT;

BACTERIA (MICROORGANISMS); MAMMALIA; NEGIBACTERIA; YERSINIA; YERSINIA PSEUDOTUBERCULOSIS;

ANIMALS; BACTERIAL OUTER MEMBRANE PROTEINS; CELL LINE; FLOW CYTOMETRY; FLUORESCENCE RESONANCE ENERGY TRANSFER; GENE SILENCING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HOST-PATHOGEN INTERACTIONS; MICE, KNOCKOUT; PROTEIN TRANSPORT; RECEPTORS, CHEMOKINE; RNA, SMALL INTERFERING; TYPE III SECRETION SYSTEMS; VIRULENCE FACTORS; YERSINIA PSEUDOTUBERCULOSIS;

EID: 84924110419     PISSN: 21612129     EISSN: 21507511     Source Type: Journal    
DOI: 10.1128/mBio.02023-14     Document Type: Article

References (50)

1. Hueck CJ. 1998. Type III protein secretion systems in bacterial pathogens of animals and plants. Microbiol Mol Biol Rev 62: 379-433.
2. Cornelis GR, Van Gijsegem F. 2000. Assembly and function of type III secretory systems. Annu Rev Microbiol 54: 735-774. http://dx. doi. org/10. 1146/annurev. micro. 54. 1. 735.
3. Büttner D, Bonas U. 2002. Port of entry-the type III secretion translocon. Trends Microbiol 10: 186-192. http://dx. doi. org/10. 1016/S0966-842X(02)02331-4.
4. Gruenheid S, Finlay BB. 2003. Microbial pathogenesis and cytoskeletal function. Nature 422: 775-781. http://dx. doi. org/10. 1038/nature01603.
5. Schlumberger MC, Hardt WD. 2006. Salmonella type III secretion effectors: pulling the host cell's strings. Curr Opin Microbiol 9: 46-54. http://dx. doi. org/10. 1016/j. mib. 2005. 12. 006.
6. Coburn B, Sekirov I, Finlay BB. 2007. Type III secretion systems and disease. Clin Microbiol Rev 20: 535-549. http://dx. doi. org/10. 1128/CMR. 00013-07.
7. Cornelis GR. 2002. The Yersinia Ysc-Yop "type III" weaponry. Nat Rev Mol Cell Biol 3: 742-752. http://dx. doi. org/10. 1038/nrm932.
8. Mueller CA, Broz P, Müller SA, Ringler P, Erne-Brand F, Sorg I, Kuhn M, Engel A, Cornelis GR. 2005. The V-antigen of Yersinia forms a distinct structure at the tip of injectisome needles. Science 310: 674-676. http://dx. doi. org/10. 1126/science. 1118476.
9. Marenne MN, Journet L, Mota LJ, Cornelis GR. 2003. Genetic analysis of the formation of the Ysc-Yop translocation pore in macrophages by Yersinia enterocolitica: role of LcrV, YscF and YopN. Microb Pathog 35: 243-258. http://dx. doi. org/10. 1016/S0882-4010(03)00154-2.
10. Cornelis GR. 2002. Yersinia type III secretion: send in the effectors. J Cell Biol 158: 401-408. http://dx. doi. org/10. 1083/jcb. 200205077.
11. Hayward RD, Cain RJ, McGhie EJ, Phillips N, Garner MJ, Koronakis V. 2005. Cholesterol binding by the bacterial type III translocon is essential for virulence effector delivery into mammalian cells. Mol Microbiol 56: 590-603. http://dx. doi. org/10. 1111/j. 1365-2958. 2005. 04568. x.
12. Schoehn G, Di Guilmi AM, Lemaire D, Attree I, Weissenhorn W, Dessen A. 2003. Oligomerization of type III secretion proteins PopB and PopD precedes pore formation in Pseudomonas. EMBO J 22: 4957-4967. http://dx. doi. org/10. 1093/emboj/cdg499.
13. van der Goot FG, Tran van Nhieu G, Allaoui A, Sansonetti P, Lafont F. 2004. Rafts can trigger contact-mediated secretion of bacterial effectors via a lipid-based mechanism. J Biol Chem 279: 47792-47798. http://dx. doi. org/10. 1074/jbc. M406824200.
14. Simons K, Ehehalt R. 2002. Cholesterol, lipid rafts, and disease. J Clin Invest 110: 597-603. http://dx. doi. org/10. 1172/JCI16390.
15. Cisz M, Lee PC, Rietsch A. 2008. ExoS controls the cell contact-mediated switch to effector secretion in Pseudomonas aeruginosa. J Bacteriol 190: 2726-2738. http://dx. doi. org/10. 1128/JB. 01553-07.
16. Mejía E, Bliska JB, Viboud GI. 2008. Yersinia controls type III effector delivery into host cells by modulating Rho activity. PLoS Pathog 4: e3. http://dx. doi. org/10. 1371/journal. ppat. 0040003.
17. Swimm AI, Kalman D. 2008. Cytosolic extract induces Tir translocation and pedestals in EPEC-infected red blood cells. PLoS Pathog 4: e4. http://dx. doi. org/10. 1371/journal. ppat. 0040004.
18. Wong KW, Isberg RR. 2005. Yersinia pseudotuberculosis spatially controls activation and misregulation of host cell Rac1. PLoS Pathog 1: e16. http://dx. doi. org/10. 1371/journal. ppat. 0010016.
19. Mohammadi S, Isberg RR. 2009. Yersinia pseudotuberculosis virulence determinants invasin, YopE, and YopT modulate RhoG activity and localization. Infect Immun 77: 4771-4782. http://dx. doi. org/10. 1128/IAI. 00850-09.
20. Pertz O, Hodgson L, Klemke RL, Hahn KM. 2006. Spatiotemporal dynamics of RhoA activity in migrating cells. Nature 440: 1069-1072. http://dx. doi. org/10. 1038/nature04665.
21. Guryanova OA, Makhanov M, Chenchik AA, Chumakov PM, Frolova EI. 2006. Optimization of a genome-wide disordered lentivector-based short hairpin RNA library. Mol Biol 40: 396-405. http://dx. doi. org/10. 1134/S002689330603006X.
22. Chung N, Zhang XD, Kreamer A, Locco L, Kuan PF, Bartz S, Linsley PS, Ferrer M, Strulovici B. 2008. Median absolute deviation to improve hit selection for genome-scale RNAi screens. J Biomol Screen 13: 149-158. http://dx. doi. org/10. 1177/1087057107312035.
23. Mi H, Muruganujan A, Casagrande JT, Thomas PD. 2013. Large-scale gene function analysis with the PANTHER classification system. Nat Protoc 8: 1551-1566. http://dx. doi. org/10. 1038/nprot. 2013. 092.
24. Viboud GI, Bliska JB. 2001. A bacterial type III secretion system inhibits actin polymerization to prevent pore formation in host cell membranes. EMBO J 20: 5373-5382. http://dx. doi. org/10. 1093/emboj/20. 19. 5373.
25. Kirchhausen T. 2000. Three ways to make a vesicle. Nat Rev Mol Cell Biol 1: 187-198. http://dx. doi. org/10. 1038/35043117.
26. Guo Y, Punj V, Sengupta D, Linstedt AD. 2008. Coat-tether interaction in Golgi organization. Mol Biol Cell 19: 2830-2843. http://dx. doi. org/10. 1091/mbc. E07-12-1236.
27. Franceschini A, Szklarczyk D, Frankild S, Kuhn M, Simonovic M, Roth A, Lin J, Minguez P, Bork P, von Mering C, Jensen LJ. 2013. String v9. 1: protein-protein interaction networks, with increased coverage and integration. Nucleic Acids Res 41: D808-D815. http://dx. doi. org/10. 1093/nar/gks1094.
28. D'Souza-Schorey C, Chavrier P. 2006. ARF proteins: roles in membrane traffic and beyond. Nat Rev Mol Cell Biol 7: 347-358. http://dx. doi. org/10. 1038/nrm1910.
29. Elvin SJ, Williamson ED, Scott JC, Smith JN, Pérez De Lema G, Chilla S, Clapham P, Pfeffer K, Schlöndorff D, Luckow B. 2004. Evolutionary genetics: ambiguous role of CCR5 in Y. pestis infection. Nature 430: 417. http://dx. doi. org/10. 1038/nature02822.
30. Mecsas J, Franklin G, Kuziel WA, Brubaker RR, Falkow S, Mosier DE. 2004. Evolutionary genetics: CCR5 mutation and plague protection. Nature 427: 606. http://dx. doi. org/10. 1038/427606a.
31. Charpentier X, Oswald E. 2004. Identification of the secretion and translocation domain of the enteropathogenic and enterohemorrhagic Escherichia coli effector Cif, using TEM-1 beta-lactamase as a new fluorescencebased reporter. J Bacteriol 186: 5486-5495. http://dx. doi. org/10. 1128/JB. 186. 16. 5486-5495. 2004.
32. Kuziel WA, Dawson TC, Quinones M, Garavito E, Chenaux G, Ahuja SS, Reddick RL, Maeda N. 2003. CCR5 deficiency is not protective in the early stages of atherogenesis in apoE knockout mice. Atherosclerosis 167: 25-32. http://dx. doi. org/10. 1016/S0021-9150(02)00382-9.
33. Marketon MM, DePaolo RW, DeBord KL, Jabri B, Schneewind O. 2005. Plague bacteria target immune cells during infection. Science 309: 1739-1741. http://dx. doi. org/10. 1126/science. 1114580.
34. Durand EA, Maldonado-Arocho FJ, Castillo C, Walsh RL, Mecsas J. 2010. The presence of professional phagocytes dictates the number of host cells targeted for Yop translocation during infection. Cell Microbiol 12: 1064-1082. http://dx. doi. org/10. 1111/j. 1462-5822. 2010. 01451. x.
35. Veiga E, Guttman JA, Bonazzi M, Boucrot E, Toledo-Arana A, Lin AE, Enninga J, Pizarro-Cerdá J, Finlay BB, Kirchhausen T, Cossart P. 2007. Invasive and adherent bacterial pathogens co-opt host clathrin for infection. Cell Host Microbe 2: 340-351. http://dx. doi. org/10. 1016/j. chom. 2007. 10. 001.
36. Bonazzi M, Vasudevan L, Mallet A, Sachse M, Sartori A, Prevost MC, Roberts A, Taner SB, Wilbur JD, Brodsky FM, Cossart P. 2011. Clathrin phosphorylation is required for actin recruitment at sites of bacterial adhesion and internalization. J Cell Biol 195: 525-536. http://dx. doi. org/10. 1083/jcb. 201105152.
37. Misselwitz B, Dilling S, Vonaesch P, Sacher R, Snijder B, Schlumberger M, Rout S, Stark M, von Mering C, Pelkmans L, Hardt WD. 2011. RNAi screen of Salmonella invasion shows role of COPI in membrane targeting of cholesterol and Cdc42. Mol Syst Biol 7: 474. http://dx. doi. org/10. 1038/msb. 2011. 7.
38. Alonzo F, III, Kozhaya L, Rawlings SA, Reyes-Robles T, DuMont AL, Myszka DG, Landau NR, Unutmaz D, Torres VJ. 2013. CCR5 is a receptor for Staphylococcus aureus leukotoxin ED. Nature 493: 51-55. http://dx. doi. org/10. 1038/nature11724.
39. Alonzo F, III, Benson MA, Chen J, Novick RP, Shopsin B, Torres VJ. 2012. Staphylococcus aureus leucocidin ED contributes to systemic infection by targeting neutrophils and promoting bacterial growth in vivo. Mol Microbiol 83: 423-435. http://dx. doi. org/10. 1111/j. 1365-2958. 2011. 07942. x.
40. Reyes-Robles T, Alonzo F, III, Kozhaya L, Lacy DB, Unutmaz D, Torres VJ. 2013. Staphylococcus aureus leukotoxin ED targets the chemokine receptors CXCR1 and CXCR2 to kill leukocytes and promote infection. Cell Host Microbe 14: 453-459. http://dx. doi. org/10. 1016/j. chom. 2013. 09. 005.
41. Duncan SR, Scott S, Duncan CJ. 2005. Reappraisal of the historical selective pressures for the CCR5-Delta32 mutation. J Med Genet 42: 205-208. http://dx. doi. org/10. 1136/jmg. 2004. 025346.
42. Balada-Llasat JM, Mecsas J. 2006. Yersinia has a tropism for B and T cell zones of lymph nodes that is independent of the type III secretion system. PLoS Pathog 2: e86. http://dx. doi. org/10. 1371/journal. ppat. 0020086.
43. Crimmins GT, Mohammadi S, Green ER, Bergman MA, Isberg RR, Mecsas J. 2012. Identification of MrtAB, an ABC transporter specifically required for Yersinia pseudotuberculosis to colonize the mesenteric lymph nodes. PLoS Pathog 8: e1002828. http://dx. doi. org/10. 1371/journal. ppat. 1002828.
44. Logsdon LK, Mecsas J. 2003. Requirement of the Yersinia pseudotuberculosis effectors YopH and YopE in colonization and persistence in intestinal and lymph tissues. Infect Immun 71: 4595-4607. http://dx. doi. org/10. 1128/IAI. 71. 8. 4595-4607. 2003.
45. Maldonado-Arocho FJ, Green C, Fisher ML, Paczosa MK, Mecsas J. 2013. Adhesins and host serum factors drive Yop translocation by Yersinia into professional phagocytes during animal infection. PLoS Pathog 9: e1003415. http://dx. doi. org/10. 1371/journal. ppat. 1003415.
46. Mecsas J, Raupach B, Falkow S. 1998. The Yersinia Yops inhibit invasion of Listeria, Shigella and Edwardsiella but not Salmonella into epithelial cells. Mol Microbiol 28: 1269-1281. http://dx. doi. org/10. 1046/j. 1365-2958. 1998. 00891. x.
47. Kent WJ, Sugnet CW, Furey TS, Roskin KM, Pringle TH, Zahler AM, Haussler D. 2002. The human genome browser at UCSC. Genome Res 12: 996-1006. http://dx. doi. org/10. 1101/gr. 229102.
48. Zlokarnik G, Negulescu PA, Knapp TE, Mere L, Burres N, Feng L, Whitney M, Roemer K, Tsien RY. 1998. Quantitation of transcription and clonal selection of single living cells with beta-lactamase as reporter. Science 279: 84-88. http://dx. doi. org/10. 1126/science. 279. 5347. 84.
49. Harmon DE, Davis AJ, Castillo C, Mecsas J. 2010. Identification and characterization of small-molecule inhibitors of Yop translocation in Yersinia pseudotuberculosis. Antimicrob Agents Chemother 54: 3241-3254. http://dx. doi. org/10. 1128/AAC. 00364-10.
50. Auerbuch V, Brockstedt DG, Meyer-Morse N, O'Riordan M, Portnoy DA. 2004. Mice lacking the type I interferon receptor are resistant to Listeria monocytogenes. J Exp Med 200: 527-533. http://dx. doi. org/10. 1084/jem. 20040976.